Keytruda provisionally approved for expanded use by an Australian regulator
Jul 18, 2019
The unfunded immunotherapy drug Keytruda, is the first drug to add additional indications for bowel cancer patients registered on the Australian Register of Therapeutic Goods via the Australian Therapeutics Goods Administration.
Read More (2 minute read)